{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:06Z","timestamp":1788873186333,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["23K07652"],"award-info":[{"award-number":["23K07652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["20H04147"],"award-info":[{"award-number":["20H04147"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["22K08281"],"award-info":[{"award-number":["22K08281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23bm1423004h0001"],"award-info":[{"award-number":["23bm1423004h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Program on Rare and Intractable Diseases, Ministry of Health, Labor, Welfare of Japan","award":["JPMH23FC1015"],"award-info":[{"award-number":["JPMH23FC1015"]}]},{"name":"Ms. Mieko Sonoda Memorial Research Fund for Interstitial Lung Diseases"},{"name":"Kyoto Health Management Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-03075-8","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T18:21:21Z","timestamp":1735064481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology"],"prefix":"10.1186","volume":"25","author":[{"given":"Michihiro","family":"Uyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminobu","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Matsunashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Niwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryobu","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Maetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi W.","family":"Nobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"3075_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1164\/ajrccm.160.3.9903021","volume":"160","author":"ZD Daniil","year":"1999","unstructured":"Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1999;160:899\u2013905.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR3","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","volume":"184","author":"RM du Bois","year":"2011","unstructured":"du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011;184:1382\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thx.2004.035436","volume":"60","author":"JJ Egan","year":"2005","unstructured":"Egan JJ, Martinez FJ, Wells AU, Williams T. Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification. Thorax. 2005;60:270\u20133.","journal-title":"Thorax"},{"key":"3075_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/thx.52.11.998","volume":"52","author":"MJ Doherty","year":"1997","unstructured":"Doherty MJ, Pearson MG, O\u2019Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52:998\u20131002.","journal-title":"Thorax"},{"key":"3075_CR7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1164\/ajrccm.155.4.9105081","volume":"155","author":"AU Wells","year":"1997","unstructured":"Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med. 1997;155:1367\u201375.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167:962\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.rmed.2017.03.006","volume":"125","author":"JH Fisher","year":"2017","unstructured":"Fisher JH, Al-Hejaili F, Kandel S, Hirji A, Shapera S, Mura M. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment. Respir Med. 2017;125:65\u201371.","journal-title":"Respir Med"},{"key":"3075_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/RTI.0000000000000220","volume":"31","author":"J Jacob","year":"2016","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Nair A, Karwoski R, et al. Automated quantitative computed tomography Versus Visual computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: validation against pulmonary function. J Thorac Imaging. 2016;31:304\u201311.","journal-title":"J Thorac Imaging"},{"key":"3075_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00408-019-00295-4","volume":"198","author":"KS Hosein","year":"2020","unstructured":"Hosein KS, Sergiacomi G, Zompatori M, Mura M. The CALIPER-Revised version of the Composite Physiologic Index is a Better Predictor of Survival in IPF than the Original Version. Lung. 2020;198:169\u201372.","journal-title":"Lung"},{"key":"3075_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1513\/AnnalsATS.202101-044OC","volume":"19","author":"T Handa","year":"2022","unstructured":"Handa T, Tanizawa K, Oguma T, Uozumi R, Watanabe K, Tanabe N, et al. Novel Artificial Intelligence-based technology for chest computed Tomography Analysis of Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2022;19:399\u2013406.","journal-title":"Ann Am Thorac Soc"},{"key":"3075_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12916-015-0479-0","volume":"13","author":"SL Walsh","year":"2015","unstructured":"Walsh SL, Wells AU, Sverzellati N, Devaraj A, von der Th\u00fcsen J, Yousem SA, et al. Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease. BMC Med. 2015;13:241.","journal-title":"BMC Med"},{"key":"3075_CR14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in Progressive Fibrosing interstitial lung diseases. N Engl J Med. 2019;381:1718\u201327.","journal-title":"N Engl J Med"},{"key":"3075_CR15","doi-asserted-by":"publisher","first-page":"00316","DOI":"10.1183\/23120541.00316-2021","volume":"7","author":"A Zhao","year":"2021","unstructured":"Zhao A, Gudmundsson E, Mogulkoc N, Jones MG, van Moorsel C, Corte TJ, et al. Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema. ERJ Open Res. 2021;7:00316\u20132021.","journal-title":"ERJ Open Res"},{"key":"3075_CR16","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","volume":"52","author":"M Kubota","year":"2014","unstructured":"Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M, et al. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242\u201350.","journal-title":"Respir Investig"},{"key":"3075_CR18","doi-asserted-by":"publisher","first-page":"2000289","DOI":"10.1183\/13993003.00289-2020","volume":"57","author":"GL Hall","year":"2021","unstructured":"Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, et al. Official ERS technical standard: global lung function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J. 2021;57:2000289.","journal-title":"Eur Respir J"},{"key":"3075_CR19","doi-asserted-by":"publisher","first-page":"1700010","DOI":"10.1183\/13993003.00010-2017","volume":"50","author":"S Stanojevic","year":"2017","unstructured":"Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, et al. Official ERS technical standards: global lung function Initiative reference values for the carbon monoxide transfer factor for caucasians. Eur Respir J. 2017;50:1700010.","journal-title":"Eur Respir J"},{"key":"3075_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/sim.4780050306","volume":"5","author":"EL Korn","year":"1986","unstructured":"Korn EL. Censoring distributions as a measure of follow-up in survival analysis. Stat Med. 1986;5:255\u201360.","journal-title":"Stat Med"},{"key":"3075_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"3075_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/sim.6370","volume":"34","author":"L Kang","year":"2015","unstructured":"Kang L, Chen W, Petrick NA, Gallas BD. Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med. 2015;34:685\u2013703.","journal-title":"Stat Med"},{"key":"3075_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344.","journal-title":"Biometrics"},{"key":"3075_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The statistical evaluation of medical tests for classification and prediction","author":"MS Pepe","year":"2003","unstructured":"Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York, USA: Oxford University Press. 2003."},{"key":"3075_CR25","doi-asserted-by":"publisher","first-page":"1601011","DOI":"10.1183\/13993003.01011-2016","volume":"49","author":"J Jacob","year":"2017","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Nair A, Karwoski R, et al. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J. 2017;49:1601011.","journal-title":"Eur Respir J"},{"key":"3075_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/thoraxjnl-2016-209671","volume":"72","author":"R Brownell","year":"2017","unstructured":"Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, et al. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017;72:424\u20139.","journal-title":"Thorax"},{"key":"3075_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12890-016-0245-x","volume":"16","author":"S Piciucchi","year":"2016","unstructured":"Piciucchi S, Tomassetti S, Ravaglia C, Gurioli C, Gurioli C, Dubini A, et al. From traction bronchiectasis to honeycombing in idiopathic pulmonary fibrosis: a spectrum of bronchiolar remodeling also in radiology? BMC Pulm Med. 2016;16:87.","journal-title":"BMC Pulm Med"},{"key":"3075_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5858\/arpa.2011-0511-OA","volume":"136","author":"KO Leslie","year":"2012","unstructured":"Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med. 2012;136:591\u2013600.","journal-title":"Arch Pathol Lab Med"},{"key":"3075_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejrad.2013.05.017","volume":"83","author":"T Johkoh","year":"2014","unstructured":"Johkoh T, Sumikawa H, Fukuoka J, Tanaka T, Fujimoto K, Takahashi M, et al. Do you really know precise radiologic-pathologic correlation of usual interstitial pneumonia? Eur J Radiol. 2014;83:20\u20136.","journal-title":"Eur J Radiol"},{"key":"3075_CR30","doi-asserted-by":"publisher","first-page":"170062","DOI":"10.1183\/16000617.0062-2017","volume":"27","author":"L Plantier","year":"2018","unstructured":"Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B. Physiology of the lung in idiopathic pulmonary fibrosis. Eur Respir Rev. 2018;27:170062.","journal-title":"Eur Respir Rev"},{"key":"3075_CR31","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","volume":"206","author":"V Cottin","year":"2022","unstructured":"Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, et al. Syndrome of Combined Pulmonary Fibrosis and Emphysema: an Official ATS\/ERS\/JRS\/ALAT Research Statement. Am J Respir Crit Care Med. 2022;206:e7\u201341.","journal-title":"Am J Respir Crit Care Med"},{"key":"3075_CR32","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","volume":"40","author":"LE Leard","year":"2021","unstructured":"Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transpl. 2021;40:1349\u201379.","journal-title":"J Heart Lung Transpl"},{"key":"3075_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.resinv.2023.08.006","volume":"61","author":"T Handa","year":"2023","unstructured":"Handa T. The potential role of artificial intelligence in the clinical practice of interstitial lung disease. Respir Investig. 2023;61:702\u201310.","journal-title":"Respir Investig"},{"key":"3075_CR34","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","volume":"160","author":"T Petnak","year":"2021","unstructured":"Petnak T, Lertjitbanjong P, Thongprayoon C, Moua T. Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: a systematic review and Meta-analysis. Chest. 2021;160:1751\u201363.","journal-title":"Chest"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-03075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-03075-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-03075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:02:28Z","timestamp":1735066948000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-03075-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3075"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-03075-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Kyoto University and the Ethics Committee of Tenri Hospital approved this study (approval numbers R1353, E2119 and No. 635, respectively). The requirement for written informed consent was waived due to the retrospective design of this study. This study was conducted in accordance with the amended Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Michihiro Uyama has no conflicts of interest; Tomohiro Handa received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited and belongs to an endowed department sponsored by Teijin Pharma Limited; Ryuji Uozumi received personal fees from Daiichi Sankyo, Eisai, Sawai Pharmaceutical, SBI Pharmaceuticals, Statcom and EPS Corporation and lecture fees from Janssen Pharmaceutical and SAS Institute Japan outside the submitted work; Seishu Hashimoto has no conflicts of interest; Yoshio Taguchi has no conflicts of interest; Kohei Ikezoe received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited; Kiminobu Tanizawa received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited; Naoya Tanabe received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited; Tsuyoshi Oguma received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited; Atsushi Matsunashi has no conflicts of interest; Takafumi Niwamoto has no conflicts of interest; Hiroshi Shima has no conflicts of interest; Ryobu Mori has no conflicts of interest; Tomoki Maetani has no conflicts of interest; Yusuke Shiraishi has no conflicts of interest; Tomomi W. Nobashi has no conflicts of interest; Ryo Sakamoto has no conflicts of interest; Takeshi Kubo has no conflicts of interest; Akihiko Yoshizawa has no conflicts of interest; Kazuhiro Terada has no conflicts of interest; Yuji Nakamoto has no conflicts of interest; and Toyohiro Hirai received a research grant from FUJIFILM Corporation and Daiichi Sankyo Company, Limited.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}